Frequency Specific Microcurrent for the Treatment of Diastasis Recti
- Conditions
- Diastasis Recti
- Interventions
- Device: INSPIRSTAR IS02 MICROCURRENT STIMULATOR
- Registration Number
- NCT04060563
- Lead Sponsor
- Diana Trang
- Brief Summary
Determine if frequency specific microcurrent therapy improves pain management of DRA by 30% or greater.
- Detailed Description
Females aged 18 years or older who are postpartum from a singleton gestation status post vaginal and with diastasis recti will be recruited. The aim of this study is to determine if frequency specific microcurrent therapy improves pain management of DRA by 30% or greater
Improving DRA after microcurrent therapy in post-partum females may allow a faster, more effective return to activity thereby improving the return-to-duty transition and establishing personal readiness by meeting military fitness standards.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 13
- Active Duty and DoD beneficiary Postpartum Females (12 hours to 24 hours) with Diastasis Rectus Abdominus (DRA) pain
- Aged 18 years or older
- Singleton gestation/delivered (one baby carried and born)
- Vaginal delivery
- Nulliparous (first pregnancy) or multiparous (more than one pregnancy in the past)
- less than 18 years of age
- females greater than 24 hours post-partum
- Medical history to include pacemaker
- History of arrhythmia
- Transplant status
- Insulin pump
- Pain pump
- Active cancer
- Inability to measure IRD
- Delivery via caesarean section
- Operative vaginal delivery (vacuum or forceps)
- 3rd or 4th degree vaginal laceration
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Frequency specific microcurrent therapy INSPIRSTAR IS02 MICROCURRENT STIMULATOR Frequency specific microcurrent therapy (100-300μA microccurrent amps) with Diastasis Recti Repair protocol (8), Sham (fake) microcurrent therapy INSPIRSTAR IS02 MICROCURRENT STIMULATOR Sham (fake) microcurrent therapy (placing the microcurrent pads on the patient and turning the microcurrent box on placebo mode )
- Primary Outcome Measures
Name Time Method Inter-rectus Distances (IRD) visit 3/week 3 Investigator will apply ultrasound gel and measure Inter-rectus distances (IRD) -- via ultrasound or if unable via ultrasound, via palpation and measuring tape -- taken at 4 locations using the medial margins of both rectus abdominis muscles:
A. 2.5 cm above the umbilical ring, B. upper margin of the umbilical ring, C. lower margin of the umbilical ring, and D. 2.5 cm below the umbilical ring.
A and D were recorded.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Mike O'Callaghan Military Medical Center
🇺🇸Nellis Air Force Base, Nevada, United States